Blood Viscosity During Long-Term Treatment with Ticlopidine in Patients with Intermittent Claudication. A Double-Blind Study

Abstract

The aim was to test within a randomized, double-blind trial whether the antiaggregant drug ticlopidine might reduce blood viscosity as has been claimed. Sixteen patients with intermittent claudication were studied before and after three years of treatment with ticlopidine, 500 mg/day, or placebo. At base line, the viscosity values were significantly higher as compared with a reference group of healthy subjects. Whole-blood viscosity, measured at four different shear rates at hematocrit adjusted to a standard 40%, decreased significantly at follow-up, with no difference between ticlopidine treatment and placebo. Hema tocrit showed a slight increase in the placebo group. The viscosity parameters were unrelated to lower limb blood flow variables, ankle/brachial index, and walking distances. The mechanism behind the overall decrease in whole-blood viscosity is obscure but could possibly be explained by lifestyle changes. Smok ing habits were, however, unaltered. Since plasma viscosity remained increased, it might indicate that some erythrocyte factor, notably red cell aggregability and deformability, had improved. It is concluded that ticlopidine had no long-term effect on blood viscosity.

Get full access to this article

View all access options for this article.

References

McTavish D. , Faulds, D. , Goa KL : Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 40:238-259, 1990.

Cloarec M. , Arcan JC , Caillard Ph , et al: Double-blind clinical trial of ticlopidine versus placebo in peripheral atherosclerotic disease of the legs. Angiologie—Act Méd Int (Boulogne) 5 (Suppl 77): 14-20, 1988.

Janzon L. , Lindgärde F. , Persson G. , et al: Prevented progression of leg arteriosclerosis with ticlopidine . Angiologie—Act Méd Int (Boulogne ) 5 (Suppl 77):21-25, 1988.

Palareti G. , Poggi M. , Torricelli P. , et al: Long-term effects of ticlopidine on fibrinogen and haemorheology in patients with peripheral arterial disease. Thromb Res 52:621-629, 1988.

Aukland A. , Hurlow RA , George AJ , et al: Platelet inhibition with ticlopidine in atherosclerotic intermittent claudication. J Clin Pathol 35:740-743, 1982.

Randi ML , Fabris F. , Crociani ME , et al: Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease. Arzneim-Forsch/ Drug Res 35:1847-1849, 1985.

Neuman V. , Cove DH , Shapiro LM , et al: Effect of ticlopidine on platelet function and blood rheology in diabetes mellitus. Clin Hemorheology 3:13-21, 1983.

Ono S. , Ashida S. , Abiko Y. : Hemorheological effect of ticlopidine in the rat. Thromb Res 31:549-556, 1983.

Janzon L. , Almgren B. , Fagher B. , et al: Prevention of myocardial infarction and stroke in patients with intermittent claudication: Effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study. J Int Med 227:301-308 & 228:659, 1990.

10.

Larsson H. : Studies of blood rheology, with special reference to hormonal changes . Thesis, Lund, 1988, pp 1-66.

11.

Larsson H. , Odeberg H. , Bohlin L. : Studies of blood viscosity with a newly constructed rotational viscometer which operates via a desk top computer. Scand J Clin Lab Invest 43:493-502, 1983.

12.

Williams WJ : Serum viscosity. In: Haematology, ed. by Beutler B , Erslev AJ , Lichtman MA. New York: McGraw-Hill, 1983, p 1660.

13.

Friedewald WT , Levy RI , Fredrickson DS : Estimation of the concentration of low-density lipoprotein cholesterol without use of the preparative ultracentrifuge . Clin Chem 18:499-506, 1972.

14.

Dahn I. : On clinical use of venous occlusion plethysmography of calf. I. Methods and controls. Acta Chir Scand 130:42-60, 1965.

15.

Dahn I. : On clinical use of venous occlusion plethysmography of calf. II. Results in patients with arterial disease. Acta Chir Scand 130:61-75, 1965.

16.

Clement DL , van Maele GO , de Pue NY : Critical evaluation of venous occlusion plethysmography in the diagnosis of occlusive arterial diseases in the lower limbs. Int Angiology 4:69-74, 1985.

17.

Dormandy JA , Hoare E. , Colley J. , et al: Clinical, haemodynamical, rheological and biochemical findings in 126 patients with intermittent claudication . Br Med J 4:576-581, 1973.

18.

Dintenfass L. : Rheology of Blood in Diagnostic and Preventive Medicine. London: Butterworths, 1976, p 47.

19.

Skovborg F. : Blood viscosity in normal and diabetic subjects. Thesis, Copenhagen, Aarhus, Odense: FADL forlag, 1974, p 64.

20.

Dormandy JA , Hoare E. , Khattab A. , et al: Prognostic significance of rheological and biochemical findings in patients with intermittent claudication . Br Med J 4:581-583, 1973.

21.

Caimi G. , Lo Presti Presti R , Serra A. , et al: Red cell filterability and erythrocyte membrane microviscosity during ticlopidine treatment. J Int Med Res 18:161-163, 1990.